XML 98 R87.htm IDEA: XBRL DOCUMENT v3.25.2
LEGAL PROCEEDINGS - Intellectual Property (Details)
1 Months Ended
Apr. 10, 2025
proceeding
Apr. 04, 2025
Mar. 28, 2025
Mar. 26, 2025
Feb. 05, 2025
Nov. 01, 2024
Sep. 27, 2024
Apr. 05, 2024
Sep. 10, 2021
Feb. 17, 2020
Mar. 31, 2021
proceeding
defendant
Norwich I Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of the approval, period                   30 months  
Amneal Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of approval, period               30 months      
Zydus Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of approval, period             30 months        
Cipla Anticipated Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of the approval, period           30 months          
Mylan Anticipated Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of the approval, period       30 months              
SABA Anticipated Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of the approval, period   30 months                  
Alkem Xifaxan Litigation                      
Loss Contingencies [Line Items]                      
Stay of the approval, period   30 months                  
The Anticipated Cabtreo Paragraph IV Proceedings                      
Loss Contingencies [Line Items]                      
Stay of the approval, period         30 months            
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb                      
Loss Contingencies [Line Items]                      
Number of defendants | defendant                     20
Number of proceedings                     17
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb                      
Loss Contingencies [Line Items]                      
Number of defendants 15                    
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb                      
Loss Contingencies [Line Items]                      
Number of defendants 2                    
Lumify Paragraph I V Proceedings Slayback ANDA Litigation | Bausch + Lomb                      
Loss Contingencies [Line Items]                      
Stay of the approval, period                 30 months    
Lumify Paragraph I V Proceedings Somerset ANDA Litigation | Bausch + Lomb                      
Loss Contingencies [Line Items]                      
Stay of the approval, period     30 months                
Lumify Paragraph I V Proceedings Gland ANDA Litigation | Bausch + Lomb                      
Loss Contingencies [Line Items]                      
Stay of the approval, period     30 months